| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |